NEW YORK, July 15 /PRNewswire-USNewswire/ -- Providing a voice to home oxygen patients nationwide, including patients with chronic obstructive pulmonary disease (COPD) and other lung diseases, the National Emphysema/COPD Association (NECA) today called the Medicare Home Oxygen Therapy Act of 2009 (H.R. 3220) a patient-focused piece of legislation that protects the best interests of the nation's 1.5 million beneficiaries and promotes quality home oxygen care.
"Home oxygen provides patients with improved quality of life by allowing them to receive oxygen safely in their home, maintain activities of daily living and remain active in their communities. We appreciate that this legislation recognizes the important patient services that oxygen users need to feel secure in their care," said Barbara Rogers, President of NECA. "As a home oxygen user, I fully understand the critical importance of the services that accompany home oxygen care. NECA strongly supports the Medicare Home Oxygen Therapy Act and encourages Congress to adopt this legislation into healthcare reform."
The Medicare Home Oxygen Therapy Act of 2009 establishes a standard set of patient services that all oxygen providers must deliver to beneficiaries, including routine patient evaluations, patient monitoring, equipment training and maintenance and emergency services, all of which play a crucial role in ensuring oxygen users are receiving the medically appropriate level of oxygen that meets their needs and allows them to live safely and comfortably. By ensuring access to these services and important patient safeguards, this legislation recognizes that home oxygen is much more than a piece of oxygen equipment; it is a healthcare service that provides life-supporting oxygen, which enables patients to breathe.
"Without home oxygen, many patients would be housebound or in a long term care facility,
|SOURCE National Emphysema/COPD Association|
Copyright©2009 PR Newswire.
All rights reserved